1183 related articles for article (PubMed ID: 28493530)
1. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
Zhu L; Fu X; Chen X; Han X; Dong P
Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
[TBL] [Abstract][Full Text] [Related]
2. Ionizing Radiation Promotes Epithelial-to-Mesenchymal Transition in Lung Epithelial Cells by TGF-β-producing M2 Macrophages.
Park HR; Jo SK; Jung U
In Vivo; 2019; 33(6):1773-1784. PubMed ID: 31662502
[TBL] [Abstract][Full Text] [Related]
3. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
6. miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II.
Zhang Q; Ye H; Xiang F; Song LJ; Zhou LL; Cai PC; Zhang JC; Yu F; Shi HZ; Su Y; Xin JB; Ma WL
Mol Ther; 2017 Mar; 25(3):728-738. PubMed ID: 28131417
[TBL] [Abstract][Full Text] [Related]
7. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mTOR ameliorates bleomycin-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition.
Han Q; Lin L; Zhao B; Wang N; Liu X
Biochem Biophys Res Commun; 2018 Jun; 500(4):839-845. PubMed ID: 29704504
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts.
Omori K; Hattori N; Senoo T; Takayama Y; Masuda T; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Kohno N
PLoS One; 2016; 11(2):e0148969. PubMed ID: 26859294
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and potential role of M2 macrophages in COPD.
He S; Xie L; Lu J; Sun S
Int J Chron Obstruct Pulmon Dis; 2017; 12():3029-3039. PubMed ID: 29089751
[TBL] [Abstract][Full Text] [Related]
11. Maresin 1 Inhibits Epithelial-to-Mesenchymal Transition in Vitro and Attenuates Bleomycin Induced Lung Fibrosis in Vivo.
Wang Y; Li R; Chen L; Tan W; Sun Z; Xia H; Li B; Yu Y; Gong J; Tang M; Ji Y; Yuan S; Shanglong Yao ; Shang Y
Shock; 2015 Nov; 44(5):496-502. PubMed ID: 26196843
[TBL] [Abstract][Full Text] [Related]
12. Multiwall carbon nanotubes directly promote fibroblast-myofibroblast and epithelial-mesenchymal transitions through the activation of the TGF-β/Smad signaling pathway.
Wang P; Wang Y; Nie X; Braïni C; Bai R; Chen C
Small; 2015 Jan; 11(4):446-55. PubMed ID: 25255886
[TBL] [Abstract][Full Text] [Related]
13. Atractylodin Suppresses TGF-β-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
Chang KW; Zhang X; Lin SC; Lin YC; Li CH; Akhrymuk I; Lin SH; Lin CC
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681813
[TBL] [Abstract][Full Text] [Related]
14. Investigating rutin as a potential transforming growth factor-β type I receptor antagonist for the inhibition of bleomycin-induced lung fibrosis.
Karunarathne WAHM; Lee KT; Choi YH; Kang CH; Lee MH; Kim SH; Kim GY
Biofactors; 2024; 50(3):477-492. PubMed ID: 38006284
[TBL] [Abstract][Full Text] [Related]
15. Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2/3 and beta-catenin pathway in human pulmonary fibrosis.
Liu G; Wang Y; Yang L; Zou B; Gao S; Song Z; Lin Z
J Cell Mol Med; 2019 May; 23(5):3583-3596. PubMed ID: 30869194
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition.
Barker TH; Dysart MM; Brown AC; Douglas AM; Fiore VF; Russell AG;
Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020
[TBL] [Abstract][Full Text] [Related]
17. Mushroom Inonotus sanghuang alleviates experimental pulmonary fibrosis: Implications for therapy of pulmonary fibrosis.
Su X; Liu K; Xie Y; Zhang M; Wu X; Zhang Y; Wang J
Biomed Pharmacother; 2021 Jan; 133():110919. PubMed ID: 33202282
[TBL] [Abstract][Full Text] [Related]
18. Tannic acid attenuates TGF-β1-induced epithelial-to-mesenchymal transition by effectively intervening TGF-β signaling in lung epithelial cells.
Pattarayan D; Sivanantham A; Krishnaswami V; Loganathan L; Palanichamy R; Natesan S; Muthusamy K; Rajasekaran S
J Cell Physiol; 2018 Mar; 233(3):2513-2525. PubMed ID: 28771711
[TBL] [Abstract][Full Text] [Related]
19. Nintedanib inhibits epithelial-mesenchymal transition in A549 alveolar epithelial cells through regulation of the TGF-β/Smad pathway.
Ihara H; Mitsuishi Y; Kato M; Takahashi F; Tajima K; Hayashi T; Hidayat M; Winardi W; Wirawan A; Hayakawa D; Kanamori K; Matsumoto N; Yae T; Sato T; Sasaki S; Takamochi K; Suehara Y; Ogura D; Niwa SI; Suzuki K; Takahashi K
Respir Investig; 2020 Jul; 58(4):275-284. PubMed ID: 32359980
[TBL] [Abstract][Full Text] [Related]
20. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
Huang X; Wang W; Yuan H; Sun J; Li L; Wu X; Luo J; Gu Y
Tohoku J Exp Med; 2016 Aug; 239(4):251-61. PubMed ID: 27439438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
